Skip to main content

Sands Capital Alternatives, LLC

Location
ARLINGTON, VA
Portfolio Value
Small $421,198,296
Diversification
Diversified
Filing Date
Global Rank
#2,859 / 8,603 ▼ 250 · as of Mar 2026
Top Industry
Biotechnology 26.0%
3Y Alpha vs SPY
-14.9%
Period ended 3 months ago
Filed May 8, 2026 · 2mo
19 quarters · since Sep 2021

Clone Performance

Jul 2023–Jul 2026 · vs SPY

Hypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.

Cloned portfolio
+17.7%
SPY
+76.0%
Annualised alpha
-15.2%
Max drawdown
−39.5%

Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.

Portfolio Concentration

21 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025
Top Position
22.3%
−0.6 pts
Top 5
68.6%
−6.8 pts
Top 10
87.0%
−1.8 pts
HHI
1,214
Jun 2023 → Mar 2026 · range 1,214 – 2,191
Diversified−338

Portfolio Trend

19 quarters · across all stocks

Sector Breakdown

As of Mar 31, 2026
Sector % Portfolio Value
Healthcare 40.5% $170,704,451
Technology 28.7% $120,736,493
Financial Services 22.3% $93,947,740
Consumer Cyclical 8.5% $35,809,612

Last Quarter's Activity

Export CSV
Mar 31, 2026 vs Dec 31, 2025

Added To

Positions the filer increased
5 positions
Ticker Δ Shares Shares Value Open

Trimmed

Positions the filer reduced
1 positions
Ticker Δ Shares Shares Value Open

New Positions

Positions the filer opened this quarter
1 positions
Ticker Shares Value Open

Sold Out

Positions the filer fully exited
No qualifying positions this quarter.

Portfolio Positions

Export CSV View 13F filing
21 positions · $421,198,296 total · as of Mar 31, 2026
Ticker Company Shares Value (USD) % of Portfolio History